IL125031A0 - Method for treating depression - Google Patents

Method for treating depression

Info

Publication number
IL125031A0
IL125031A0 IL12503196A IL12503196A IL125031A0 IL 125031 A0 IL125031 A0 IL 125031A0 IL 12503196 A IL12503196 A IL 12503196A IL 12503196 A IL12503196 A IL 12503196A IL 125031 A0 IL125031 A0 IL 125031A0
Authority
IL
Israel
Prior art keywords
treating depression
depression
treating
Prior art date
Application number
IL12503196A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL125031A0 publication Critical patent/IL125031A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL12503196A 1995-12-22 1996-12-04 Method for treating depression IL125031A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US917395P 1995-12-22 1995-12-22
PCT/US1996/019574 WO1997023220A1 (en) 1995-12-22 1996-12-04 Method for treating depression

Publications (1)

Publication Number Publication Date
IL125031A0 true IL125031A0 (en) 1999-01-26

Family

ID=21736023

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12503196A IL125031A0 (en) 1995-12-22 1996-12-04 Method for treating depression

Country Status (15)

Country Link
US (1) US5958921A (no)
EP (1) EP0868185A4 (no)
JP (1) JP2000502345A (no)
KR (1) KR19990076689A (no)
AU (1) AU705834B2 (no)
CA (1) CA2241153A1 (no)
CZ (1) CZ198498A3 (no)
EA (1) EA000745B1 (no)
HU (1) HUP9903684A3 (no)
IL (1) IL125031A0 (no)
MX (1) MX9805064A (no)
NO (1) NO982911D0 (no)
NZ (1) NZ325036A (no)
PL (1) PL327600A1 (no)
WO (1) WO1997023220A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0796619A1 (en) 1996-03-21 1997-09-24 Merrell Pharmaceuticals Inc. Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders
US5968921A (en) 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
JP2002530341A (ja) 1998-11-23 2002-09-17 セプラコール， インク． デスメチルオランザピン組成物及び方法
JP2002530339A (ja) 1998-11-23 2002-09-17 セプラコール， インク． ２−ヒドロキシメチルオランザピン組成物及び方法
JP2002530340A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． オランザピン−ｎ−オキサイドを含む医薬組成物
MXPA05000294A (es) * 2002-07-30 2005-08-19 Peter Migaly Terapia combinada para la depresion, prevencion de suicidios y varias condiciones medicas y psiquiatricas.
AR042806A1 (es) * 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
CN1989968B (zh) 2002-12-27 2011-05-11 大塚制药株式会社 用于治疗情绪障碍的喹诺酮衍生物和5-羟色胺再摄取抑制剂
US20050181071A1 (en) * 2004-02-18 2005-08-18 Binder Michael R. Method for the treatment of clinical depression
US20150190403A1 (en) 2012-07-31 2015-07-09 Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi Use of olanzapine in animals
US20150216206A1 (en) 2012-07-31 2015-08-06 Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi Method for increasing meat and milk production
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605504D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel chroman derivatives
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
AU705834B2 (en) 1999-06-03
CZ198498A3 (cs) 1999-03-17
HUP9903684A2 (hu) 2000-03-28
HUP9903684A3 (en) 2001-12-28
MX9805064A (es) 1998-10-31
US5958921A (en) 1999-09-28
KR19990076689A (ko) 1999-10-15
EP0868185A4 (en) 2002-04-10
EP0868185A1 (en) 1998-10-07
NZ325036A (en) 2001-06-29
AU1284797A (en) 1997-07-17
NO982911L (no) 1998-06-22
PL327600A1 (en) 1998-12-21
CA2241153A1 (en) 1997-07-03
JP2000502345A (ja) 2000-02-29
WO1997023220A1 (en) 1997-07-03
NO982911D0 (no) 1998-06-22
EA199800590A1 (ru) 1998-12-24
EA000745B1 (ru) 2000-02-28

Similar Documents

Publication Publication Date Title
IL122718A0 (en) Methods for treating diabetes
PL323178A1 (en) Schirophrenia diagnosin method
AU1074397A (en) Method for treating anxiety
IL125031A0 (en) Method for treating depression
GB9519638D0 (en) Method
GB9518442D0 (en) Method
AU4901896A (en) Method for treating multiple sclerosis
AU7726396A (en) Method for treating anxiety
GB2308522B (en) Redialling method
IL124786A0 (en) Method for treating pain
AU7674796A (en) Method for treating anxiety
AU4703896A (en) Method for treating multiple sclerosis
GB9502225D0 (en) Method
GB9510727D0 (en) Method
AP9701121A0 (en) Method for prearing streptogramines
GB9511828D0 (en) Method
IL117635A (en) Method for controlling acridians
GB9722553D0 (en) Method
AU2198997A (en) Method for treating insomnia
GB9513130D0 (en) Treatment method
GB9513129D0 (en) Treatment method
GB9511594D0 (en) Treatment method
HU9503661D0 (en) Method for impregnation
GB9505179D0 (en) Process for fluoroaromatics
PL316000A1 (en) Watertreating method